Crown BioScience experts explore organoid models and high-content imaging to evaluate T-cell-targeted therapies and ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

Cyclin D1–CDK4/6 phosphorylates GTSE1 in cancer cells, preventing its degradation and sustaining high levels across the cell cycle, which enhances proliferation and correlates with poor prognosis.

Breast cancer is becoming increasingly treatable, but in some cases the disease can resurface even decades after a patient ...

Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung ...

Approach: We leverage variations in cell cycle state as a natural barcode to link data across different modalities. We have demonstrated the feasibility of this method in a gastric cancer cell line ...

Review highlights how vitamin D, particularly its active form calcitriol, modulates immune responses, inflammation, and tumor ...

The combination synergistically inhibited cancer cell proliferation by inducing cell cycle arrest at G0/G1 and G2/M phases. It also impaired homologous recombination repair, as evidenced by reduced ...

A parasitic worm may raise the risk of cervical cancer through several mechanisms, scientists have found, although HPV ...

DelveInsight's "IBRANCE Market Size, Forecast, and Market Insight Report" highlights the details around IBRANCE, a CDK4/6 ...